Bay Area biotech company Synthego, raised $392M, forced into bankruptcy sfgate.com 4 points by randycupertino 7 hours ago
duxup 6 hours ago Biotech seems to historically require a lot of iterations / failures before breakthroughs happen.I'm not sure the typical VC "startup" type expectations / speed really lends itself to that kind of business.
hoseyor 6 hours ago I wonder if that was private lending/credit. There seems to be a huge issue building in that unregulated space.
Biotech seems to historically require a lot of iterations / failures before breakthroughs happen.
I'm not sure the typical VC "startup" type expectations / speed really lends itself to that kind of business.
I wonder if that was private lending/credit. There seems to be a huge issue building in that unregulated space.